Encompass Health reports Q1 2024 earnings; figures not extractable from provided text

Encompass Health Corp

2024-Q1 EPS reported $1.10 revenue$1,316,000,000

The 8-K references a press release (Exhibit 99.1) and supplemental slides (Exhibit 99.2) for Q1 2024 results.
Actual revenue, EPS, and other key metrics are missing from the filing text supplied; exhibits appear truncated.
Non-GAAP definitions and forward-looking statements are included, but no concrete earnings numbers are visible.
Investors should refer to the full press release and earnings call materials for specific financial data.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Encompass Health Corp reported financial results for the three months ended March 31, 2024.

Period: the three months ended March 31, 2024
Result: reported results

Exact text from the filing

On April 24, 2024, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three months ended March 31, 2024.

View on SEC.gov

493 earnings releases filed in the last 30 days. Browse all earnings releases →

Encompass Health Corp filing history →

Source: SEC EDGAR

accession 0000785161-24-000025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.